Meeting Banner
Abstract #4574

Evaluation of a Non-Enhanced MRI Protocol Compared to Gadolinium-Enhanced MRI for Hepatocellular Carcinoma

Andrew Dean Hardie1

1Radiology, Medical University of South Carolina, Charleston, SC, United States

MRI is accurate for identifying hepatocellular carcinoma however gadolinium chelates are contraindicated in patients with severe renal dysfunction due to the risk of Nephrogenic Systemic Fibrosis. There is a need to develop clinically usefull non-contrast MRI techniques to image these patients. Diffusion-weighted imaging and T2* weighted imaging offer the ability to identify tumors in cirrhotic patients with an accuracy similar to gadolinium MRI.